Furthermore, at day 58 combination treatment of Ad5WS1 and Ad/K1–5 inhibited tumour growth compared with Ad5WS1-treated (P=0.05) or Ad/K1–5-treated (P=0.0018) mice. This evidence concerns the gene KRT1 and neoplasm.